{"transactions":[{"id":2680853,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":138633,"kind":"person","name":"OLANOFF LAWRENCE S","position":1,"cik":"0001224341","reported_name":"OLANOFF LAWRENCE S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-04T20:16:43.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":22766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":91395,"source":{"system":"sec-edgar","filing":"0001209191-21-038213","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919121038213/doc4.xml","form_type":"4"}},{"id":3111789,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":138633,"kind":"person","name":"OLANOFF LAWRENCE S","position":1,"cik":"0001224341","reported_name":"OLANOFF LAWRENCE S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2020-06-12T20:32:31.000Z","date":"2020-06-10","kind":"sale","acquired":false,"shares":11350,"price":10.06,"value":114181.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.80 to $10.78,\ninclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange\nCommission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this\nfootnote."}],"balance_after":68629,"source":{"system":"sec-edgar","filing":"0001209191-20-036289","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919120036289/doc4.xml","form_type":"4"}},{"id":3120232,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":138633,"kind":"person","name":"OLANOFF LAWRENCE S","position":1,"cik":"0001224341","reported_name":"OLANOFF LAWRENCE S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2020-06-05T20:37:57.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":21720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":79979,"source":{"system":"sec-edgar","filing":"0001209191-20-034699","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919120034699/doc4.xml","form_type":"4"}},{"id":3497099,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":138633,"kind":"person","name":"OLANOFF LAWRENCE S","position":1,"cik":"0001224341","reported_name":"OLANOFF LAWRENCE S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2019-06-07T20:06:57.000Z","date":"2019-06-05","kind":"sale","acquired":false,"shares":2000,"price":11.25,"value":22500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $11.17 to $11.37, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":58259,"source":{"system":"sec-edgar","filing":"0001209191-19-035513","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119035513/doc4.xml","form_type":"4"}},{"id":3506294,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":138633,"kind":"person","name":"OLANOFF LAWRENCE S","position":1,"cik":"0001224341","reported_name":"OLANOFF LAWRENCE S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2019-05-31T20:15:23.000Z","date":"2019-05-29","kind":"grant","acquired":true,"shares":22706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the director compensation policy, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":60259,"source":{"system":"sec-edgar","filing":"0001209191-19-033637","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119033637/doc4.xml","form_type":"4"}},{"id":3608279,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":138633,"kind":"person","name":"OLANOFF LAWRENCE S","position":1,"cik":"0001224341","reported_name":"OLANOFF LAWRENCE S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2019-03-06T21:06:00.000Z","date":"2019-03-05","kind":"sale","acquired":false,"shares":2000,"price":14.41,"value":28820.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.16 to $14.67, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":37553,"source":{"system":"sec-edgar","filing":"0001209191-19-017301","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119017301/doc4.xml","form_type":"4"}},{"id":3737558,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":138633,"kind":"person","name":"OLANOFF LAWRENCE S","position":1,"cik":"0001224341","reported_name":"OLANOFF LAWRENCE S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2018-12-10T21:37:29.000Z","date":"2018-12-06","kind":"sale","acquired":false,"shares":2000,"price":12.47,"value":24940.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards."}],"balance_after":39553,"source":{"system":"sec-edgar","filing":"0001209191-18-061788","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919118061788/doc4.xml","form_type":"4"}},{"id":3821960,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":138633,"kind":"person","name":"OLANOFF LAWRENCE S","position":1,"cik":"0001224341","reported_name":"OLANOFF LAWRENCE S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2018-09-07T20:01:54.000Z","date":"2018-09-05","kind":"sale","acquired":false,"shares":2000,"price":19.1,"value":38200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.90 to $19.26, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":41553,"source":{"system":"sec-edgar","filing":"0001209191-18-050031","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919118050031/doc4.xml","form_type":"4"}},{"id":3901548,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":138633,"kind":"person","name":"OLANOFF LAWRENCE S","position":1,"cik":"0001224341","reported_name":"OLANOFF LAWRENCE S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2018-06-07T20:26:20.000Z","date":"2018-06-05","kind":"sale","acquired":false,"shares":2000,"price":17.62,"value":35240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.40 to $17.87, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":43553,"source":{"system":"sec-edgar","filing":"0001209191-18-036352","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919118036352/doc4.xml","form_type":"4"}},{"id":3908257,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":138633,"kind":"person","name":"OLANOFF LAWRENCE S","position":1,"cik":"0001224341","reported_name":"OLANOFF LAWRENCE S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2018-06-04T21:29:45.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":16223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Director Compensation Plan, effective as of January 2014."}],"balance_after":45553,"source":{"system":"sec-edgar","filing":"0001209191-18-035249","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919118035249/doc4.xml","form_type":"4"}},{"id":4010803,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":138633,"kind":"person","name":"OLANOFF LAWRENCE S","position":1,"cik":"0001224341","reported_name":"OLANOFF LAWRENCE S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2018-03-07T00:17:06.000Z","date":"2018-03-05","kind":"sale","acquired":false,"shares":2000,"price":14.05,"value":28100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.98 to $14.13, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":29330,"source":{"system":"sec-edgar","filing":"0001209191-18-017511","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919118017511/doc4.xml","form_type":"4"}},{"id":4140334,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":138633,"kind":"person","name":"OLANOFF LAWRENCE S","position":1,"cik":"0001224341","reported_name":"OLANOFF LAWRENCE S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2017-12-06T21:14:06.000Z","date":"2017-12-04","kind":"sale","acquired":false,"shares":1900,"price":16.48,"value":31312.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards."},{"field":"shares","element":"transactionShares","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.21 to $17.09, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.21 to $17.09, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":31330,"source":{"system":"sec-edgar","filing":"0001209191-17-064179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919117064179/doc4.xml","form_type":"4"}},{"id":4140333,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":138633,"kind":"person","name":"OLANOFF LAWRENCE S","position":1,"cik":"0001224341","reported_name":"OLANOFF LAWRENCE S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2017-12-06T21:14:06.000Z","date":"2017-12-04","kind":"sale","acquired":false,"shares":100,"price":16.09,"value":1609.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards."}],"balance_after":33230,"source":{"system":"sec-edgar","filing":"0001209191-17-064179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919117064179/doc4.xml","form_type":"4"}},{"id":4214685,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":138633,"kind":"person","name":"OLANOFF LAWRENCE S","position":1,"cik":"0001224341","reported_name":"OLANOFF LAWRENCE S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2017-09-07T20:40:15.000Z","date":"2017-09-05","kind":"sale","acquired":false,"shares":2000,"price":16.15,"value":32300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.02 to $16.30, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":33330,"source":{"system":"sec-edgar","filing":"0001209191-17-051890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919117051890/doc4.xml","form_type":"4"}},{"id":4285462,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":138633,"kind":"person","name":"OLANOFF LAWRENCE S","position":1,"cik":"0001224341","reported_name":"OLANOFF LAWRENCE S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2017-06-12T20:27:32.000Z","date":"2017-06-08","kind":"sale","acquired":false,"shares":3200,"price":17.78,"value":56896.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.61 to $18.00, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":35330,"source":{"system":"sec-edgar","filing":"0001209191-17-039167","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919117039167/doc4.xml","form_type":"4"}},{"id":4295696,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":138633,"kind":"person","name":"OLANOFF LAWRENCE S","position":1,"cik":"0001224341","reported_name":"OLANOFF LAWRENCE S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2017-06-02T21:02:50.000Z","date":"2017-05-31","kind":"grant","acquired":true,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Director Compensation Plan, effective as of January 2014."}],"balance_after":38530,"source":{"system":"sec-edgar","filing":"0001209191-17-037354","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919117037354/doc4.xml","form_type":"4"}},{"id":4337836,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":138633,"kind":"person","name":"OLANOFF LAWRENCE S","position":1,"cik":"0001224341","reported_name":"OLANOFF LAWRENCE S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-02T21:07:20.000Z","date":"2017-04-28","kind":"grant","acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of this option will vest one year after the date of grant. The option allows for early exercise, subject to the issuer's repurchase option with respect to any unvested common shares. All common shares\nunderlying such option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes only options with the same termination date."}],"balance_after":27000,"derivative":{"exercise_price":24.24,"expiration_date":"2027-04-28","underlying":"Common Shares","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001209191-17-029474","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1224341/000120919117029474/doc4.xml","form_type":"4"}},{"id":4397326,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":138633,"kind":"person","name":"OLANOFF LAWRENCE S","position":1,"cik":"0001224341","reported_name":"OLANOFF LAWRENCE S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2017-03-07T22:32:37.000Z","date":"2017-03-03","kind":"sale","acquired":false,"shares":3200,"price":17.19,"value":55008.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.99 to $17.43, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":22905,"source":{"system":"sec-edgar","filing":"0001209191-17-018896","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919117018896/doc4.xml","form_type":"4"}},{"id":4529887,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":138633,"kind":"person","name":"OLANOFF LAWRENCE S","position":1,"cik":"0001224341","reported_name":"OLANOFF LAWRENCE S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2016-12-07T23:57:05.000Z","date":"2016-12-05","kind":"sale","acquired":false,"shares":3200,"price":15.68,"value":50176.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.40 to $15.82, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":26105,"source":{"system":"sec-edgar","filing":"0001209191-16-154010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919116154010/doc4.xml","form_type":"4"}},{"id":4609329,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":138633,"kind":"person","name":"OLANOFF LAWRENCE S","position":1,"cik":"0001224341","reported_name":"OLANOFF LAWRENCE S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2016-09-07T23:06:06.000Z","date":"2016-09-06","kind":"sale","acquired":false,"shares":3200,"price":13.72,"value":43904.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.49 to $13.89, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":29305,"source":{"system":"sec-edgar","filing":"0001209191-16-140466","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919116140466/doc4.xml","form_type":"4"}}]}